CellCentric
PrivateLast Round
Series D
May 6, 2026
Est. Valuation
$900M
Total Funding Raised
$436.58M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellCentric is a biotechnology company that develops clinical-stage small-molecule inhibitors targeting p300/CBP for the treatment of multiple myeloma and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellCentric Comparables
Compare CellCentric with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Karyopharm Therapeutics | 78% | |
| C4 Therapeutics | 74% | |
| Opna Bio | 74% | |
CellCentric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 6, 2026 | ||||
| Series C | May 19, 2025 | ||||
| Series B | Jul 24, 2024 | ||||
| VC Round | Sep 11, 2023 | ||||
| Convertible Debt | Jul 11, 2023 | ||||
VC Round | Jan 26, 2022 |
Key People
Founding team and executive leadership
CellCentric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series D, Series C |
| Forbion Capital Partners | Series C |
| RA Capital Management | Series D, Series C, Series B |
| Future Planet Capital Regional | Grant |
| Forbion | Series D, Series C |
| BrightEdge | Series C, Series B, VC Round |
| Morningside Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$220M round led by Venrock.
- Dec 19, 2025
Inobrodib enters Phase 3 trial for multiple myeloma and other cancers.
CellCentric Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellCentric's valuation, stock price, and market status.